Envisagenics

Debrief: Keeping busy with Phil Rugile

There’s never a dull moment when you’re Phil Rugile, who pulls double duty as director of the hyperactive LaunchPad Huntington and as “human capital strategist” at eGifter, the Huntington-based digital gifting/corporate prepaid solutions specialist that remains one of Long Island’s great innovation success stories. When Innovate LI last Debriefed the media-savvy entrepreneur, LaunchPad Huntington was barely a year old and still finding its way; two years hence, Rugile has honed the co-working space into a…


Andrew Whiteley is now executively in residence

By GREGORY ZELLER // It’s become vogue for research institutions to staff “entrepreneurs-in-residence,” experienced innovators who can help science-based startups find their commercial footing, because they’ve been there and done that. Leave it to Cold Spring Harbor Laboratory to give the notion an innovative spin with a first-ever “executive-in-residence,” a 25-year life-sciences and drug-discovery veteran named Andrew Whiteley. In Whiteley, the lab doesn’t really have an entrepreneur – he’s never actually launched a new business himself – but it does…


Envisagenics lands $225K NIH award

Bioinformatics startup Envisagenics has been awarded a $225,000 award from the National Institutes of Health. The Phase I Small Business Innovation Research Award is the largest capital infusion to date for the LaunchPad Huntington resident, which received $100,000 last month from an Accelerate Long Island seed fund. The firm, a spinoff from Cold Spring Harbor Laboratory, will dedicate the $225,000 to the development of SpliceCore, a cloud-based platform for detecting, quantifying and interpreting NGS data…


Envisagenics gets $100K in seed funding

By GREGORY ZELLER // Cold Spring Harbor Laboratory spinoff Envisagenics has landed a $100,000 investment from Accelerate Long Island and the Long Island Emerging Technology Fund. Envisagenics, which uses proprietary algorithms to dramatically reduce the complexity of biological datasets resulting from ribonucleic acid sequencing, will use the funds “to create the most talented team possible for Envisagenics and Long Island,” CEO Maria Luisa Pineda told Innovate LI. Pineda founded the firm in 2013 with Chief Technology…


Helping Big Pharma master Big Data

By GREGORY ZELLER // Medicine is making giant strides in the research of ribonucleic acid – RNA for short – a molecule that plays vital roles in the coding, decoding and regulation of genes. The stumbling block is the resulting data, which has been piling up from next-generation sequencing technology and will soon represent the largest collection of electronic bytes in the world, topping even the astronomical amounts of data collected on space. And even…